[1]
Al-Shammari, A.H. and Mohammed Abd Ali Shahadha 2022. The effect of Favipiravir on liver enzyme among patients with mild to moderate COVID-19 infection: A prospective cohort study . Journal of Population Therapeutics and Clinical Pharmacology. 29, 04 (Dec. 2022), 46–54. DOI:https://doi.org/10.47750/jptcp.2022.967.